Article

Phenotype and function of human natural killer cells purified by using a clinical-scale immunomagnetic method.

Department of Hematology-Oncology, St. Jude Children's Research Hospital, Mail Stop 260, 332 N. Lauderdale Street, Memphis, TN 38105, USA.
Cancer Immunology and Immunotherapy (Impact Factor: 3.94). 05/2005; 54(4):389-94. DOI: 10.1007/s00262-004-0609-6
Source: PubMed

ABSTRACT Infection, disease relapse, graft failure, and graft-versus-host disease (GVHD) are significant adverse events associated with allogeneic bone marrow transplantation. Donor natural killer (NK) cells may be an ideal cell type for prevention or treatment of all these adverse events. Therefore, we investigated the phenotype and function of human NK cells purified by using a clinical-scale immunomagnetic method. We found that the NK cell purification procedures did not adversely affect the expression of killer cell immunoglobulin-like receptors, adhesion molecules, intracellular cytokines, perforin, and granzyme B. Purified NK cells had extensive proliferative capacity and potent antitumor activity when assessed using an immunodeficient mouse model. While all mice transplanted with unpurified mononuclear cells developed GVHD, none of the mice transplanted with purified NK cells did. NK cells were highly susceptible to lysis by antithymocyte globulin (ATG), whereas G-CSF had a minimal effect on their natural cytotoxicity. These results support future clinical investigation of the use of purified NK cells for adoptive immunotherapy in the absence of ATG.

0 Bookmarks
 · 
84 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Analogous to T cells, Natural Killer (NK) cells may facilitate engraftment, combat infection, and control cancer in bone marrow or haematopoietic stem cell transplantation (HSCT); however, NK cells do not cause graft-versus-host disease. Killer immunoglobulin-like receptors (KIRs) regulate NK cell function, and recent data suggest that KIR is as important as its ligand (human leucocyte antigen; HLA) in HSCT for both malignant and non-malignant conditions. Because there is substantial variability in KIR gene content, allelic polymorphism, and cell-surface expression among people, careful selection of donors based on HLA and KIR is essential to optimize HSCT outcomes. Furthermore, NK cells may be used for adoptive immunotherapy after HSCT in place of conventional donor lymphocyte infusion, as part of pre-transplant cytoreductive therapy, or as an independent therapeutic agent in high-risk leukaemia in place of sibling donor HSCT.
    British Journal of Haematology 08/2011; 155(1):14-29. · 4.94 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Adoptive immunotherapy using natural killer (NK) cells has been a promising treatment for intractable malignancies; however, there remain a number of difficulties with respect to the shortage and limited anticancer potency of the effector cells. We here established a simple feeder-free method to generate purified (>90%) and highly activated NK cells from human peripheral blood-derived mononuclear cells (PBMCs). Among the several parameters, we found that simply 1) CD3-depletion, 2) high dose IL-2, and 3) use of a specific culture medium were sufficient to obtain highly purified, expanded (~200-fold) and activated CD3-/CD56+ NK cells from PBMCs that we named zenithal-NK cells (Z-NK). Almost all Z-NK cells expressed the lymphocyte-activated marker CD69, and showed dramatically high expression of activation receptors (i.e., NKG2D), interferon-γ, perforin and granzyme B. Importantly, only 2 hours of reaction at an effector/target ratio of 1:1 was sufficient to kill almost all K562 cells, and the antitumor activity was also replicated in tumor-bearing mice in vivo. Cytolysis was specific for various tumor cells, but not for normal cells, irrespective of MHC class I expression. These findings strongly indicate that Z-NK cells are purified, expanded, and near-fully activated human NK cells and warrant further investigation in a clinical setting.
    Human Gene Therapy Methods 07/2013; · 1.64 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The electron beam irradiation sterilization is placed first among all types of medical items sterilization. The quality of sterilization is determined by value of dose, which is in one's turn determined by beam current, electron energy and beam scanning system parameters. Therefore these parameters have to be controlled during the irradiation process. The equipment for beam current and electron energy monitoring allows to control beam current, electron energy spectrum and nominal deflection of electron beam when scanning during the irradiation process each scanning period or, for example, each tenth scanning period by request. The equipment consists of an induction beam current sensor with registration equipment and two grounded electron collectors. The simplicity of this equipment allows to use it for irradiation quality monitoring practically in all electron beam irradiation technology processes
    01/1997;

Full-text (2 Sources)

Download
6 Downloads
Available from
Jul 10, 2014